Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines
- 15 September 2011
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (18), 5171-5176
- https://doi.org/10.1016/j.bmcl.2011.07.059
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Inhibition of Antibiotic-Resistant Staphylococcus aureus by the Broad-Spectrum Dihydrofolate Reductase Inhibitor RAB1Antimicrobial Agents and Chemotherapy, 2010
- Antistaphylococcal Activity of Dihydrophthalazine Antifolates, a Family of Novel Antibacterial DrugsAntimicrobial Agents and Chemotherapy, 2009
- Synthetic and Crystallographic Studies of a New Inhibitor Series Targeting Bacillus anthracis Dihydrofolate ReductaseJournal of Medicinal Chemistry, 2008
- DNA and RNA Synthesis: AntifolatesChemical Reviews, 2005
- Structure, Dynamics, and Catalytic Function of Dihydrofolate ReductaseAnnual Review of Biophysics and Biophysical Chemistry, 2004
- IclaprimDrugs of the Future, 2004
- Resistance to Trimethoprim-SulfamethoxazoleClinical Infectious Diseases, 2001
- Antifolate and antibacterial activities of 6-substituted 2,4-diaminoquinazolinesEuropean Journal of Medicinal Chemistry, 1992
- Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolinesJournal of Medicinal Chemistry, 1990
- Direct synthesis of 2,4‐diaminoquinazolines from 2‐fluorobenzonitrilesJournal of Heterocyclic Chemistry, 1988